MSH6 and colorectal carcinoma: In our opinion, future studies should focus on distinguishing more personalised surveillance intervals for different LS associated gPV groups, possibly enabling extension of surveillance intervals for individuals with MSH6 and/or PMS2 gPVs given the smaller lifetime risks of developing CRC.